Insulin Glargine View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-08

AUTHORS

Christopher J. Dunn, Greg L. Plosker, Gillian M. Keating, Kate McKeage, Lesley J. Scott

ABSTRACT

Insulin glargine is a human insulin analogue prepared by recombinant DNA technology. Modification of the human insulin molecule at position A21 and at the C-terminus of the B-chain results in the formation of a stable compound that is soluble at pH 4.0, but forms amorphous microprecipitates in subcutaneous tissue from which small amounts of insulin glargine are gradually released. The plasma concentration versus time profile of insulin glargine is therefore relatively constant in relation to conventional human insulins, with no pronounced peak over 24 hours. This allows once-daily administration as basal therapy. Early randomised trials with insulin glargine generally showed greater reductions in fasting blood or plasma glucose levels and a reduced frequency of nocturnal hypoglycaemia relative to neutral protamine Hagedorn (NPH) insulin in patients with type 1 diabetes mellitus. In addition to this basal therapy, patients continued to use the regular mealtime insulin regimen to which they were accustomed. More recent data with insulin glargine have included evidence of improved glycaemic control, with improvements in satisfaction with treatment over NPH insulin. Furthermore, the time of day at which insulin glargine is injected has no clinically relevant effect on glycaemic control in these patients. There are also data from small, nonblind studies to suggest comparable glycaemic control with insulin glargine and continuous subcutaneous insulin infusion. Results from comparative studies and meta-analyses in individuals with type 2 diabetes show lower incidences of nocturnal hypoglycaemia with insulin glargine than with NPH insulin, with two studies showing a significantly greater improvement in glycosylated haemoglobin levels with insulin glargine than with NPH. Insulin glargine is well tolerated, and is not associated with greater immunogenicity or increases in bodyweight than NPH insulin. Long-term data show maintenance of glycaemic control with insulin glargine for up to 39 months in adults and children with type 1 and adults with type 2 diabetes. In conclusion, insulin glargine is an effective and well tolerated basal insulin therapy when given as a single daily subcutaneous injection to patients with diabetes, with benefits in terms of glycaemic control and reduced frequency of hypoglycaemia over regimens based on conventional basal insulins. Accumulating data and official recommendations show the suitability of insulin glargine for first-line use in selected patients with type 2 diabetes who require insulin treatment, as well as in patients with type 1 disease, and confirm its use in children and adolescents. More... »

PAGES

1743-1778

References to SciGraph publications

  • 2001-09. Insulin Glargine in DRUGS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.2165/00003495-200363160-00007

    DOI

    http://dx.doi.org/10.2165/00003495-200363160-00007

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1009958899

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/12904090


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Diabetes Mellitus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Schedule", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Injections, Subcutaneous", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin Glargine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin, Long-Acting", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Time Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "United Kingdom", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Springer (New Zealand)", 
              "id": "https://www.grid.ac/institutes/grid.420067.7", 
              "name": [
                "Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dunn", 
            "givenName": "Christopher J.", 
            "id": "sg:person.0700313355.98", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700313355.98"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Springer (New Zealand)", 
              "id": "https://www.grid.ac/institutes/grid.420067.7", 
              "name": [
                "Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Plosker", 
            "givenName": "Greg L.", 
            "id": "sg:person.0726406660.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726406660.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Springer (New Zealand)", 
              "id": "https://www.grid.ac/institutes/grid.420067.7", 
              "name": [
                "Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Keating", 
            "givenName": "Gillian M.", 
            "id": "sg:person.01175750452.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175750452.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Springer (New Zealand)", 
              "id": "https://www.grid.ac/institutes/grid.420067.7", 
              "name": [
                "Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McKeage", 
            "givenName": "Kate", 
            "id": "sg:person.01100307753.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100307753.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Springer (New Zealand)", 
              "id": "https://www.grid.ac/institutes/grid.420067.7", 
              "name": [
                "Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Scott", 
            "givenName": "Lesley J.", 
            "id": "sg:person.01244653776.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244653776.31"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1136/bmj.321.7258.405", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000154862"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.25.9.1666", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000728386"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.11.1666", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000892396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.2.157", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000907601"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1464-5491.2003.00999.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001455083"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.4.1322", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001924345"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm199309303291401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004144761"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.5.639", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005928670"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/00000446-200208000-00039", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007787360"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/00000446-200208000-00039", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007787360"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0169-409x(98)00079-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011220920"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm200002103420603", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012627827"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diabetes.49.12.2142", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012893424"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003495-200161110-00007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013714316", 
              "https://doi.org/10.2165/00003495-200161110-00007"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003495-200161110-00007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013714316", 
              "https://doi.org/10.2165/00003495-200161110-00007"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0014-2999(96)00903-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013847532"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/pdi.383", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013862196"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.25.9.1597", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013972289"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(98)07037-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015697368"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.6.1738", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018387725"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(98)07019-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018881858"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1399-5448.2007.00252.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019524362"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/jama.289.17.2254", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019986510"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1185/030079902125001416", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022039494"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.24.4.631", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022125555"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1464-5491.2002.00723.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022928206"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1464-5491.2001.00529.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023118109"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.7.2194", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027671378"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1136/bmj.316.7139.1221", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028197140"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1515/jpem.2002.15.4.369", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029076833"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1053/bega.2002.0321", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030345651"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(00)02546-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032757605"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/003655100750019242", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034245644"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.4.1321", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035157988"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.5.1490", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038524974"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1463-1326.2000.00109.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038882295"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.25.6.1103-a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039095989"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.5.644", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040323572"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.2007.s25", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045453861"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.8.1137", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046985393"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.2007.s33", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047132498"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.3.799", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047194220"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.8.1130", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050330235"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.26.2007.s28", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051982466"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.23.6.813", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052130317"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diabetes.49.6.999", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052181318"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1055/s-2003-39080", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1057421544"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1055/s-2007-978849", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1057508289"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/10915810290096306", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058377172"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/10915810290096306", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058377172"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/10915810290096315", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058377173"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/10915810290096315", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058377173"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/edrv.22.5.0442", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064238544"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/jcem.86.12.8110", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064324076"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.7326/0003-4819-138-12-200306170-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1073706003"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074272220", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1075003279", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2003-08", 
        "datePublishedReg": "2003-08-01", 
        "description": "Insulin glargine is a human insulin analogue prepared by recombinant DNA technology. Modification of the human insulin molecule at position A21 and at the C-terminus of the B-chain results in the formation of a stable compound that is soluble at pH 4.0, but forms amorphous microprecipitates in subcutaneous tissue from which small amounts of insulin glargine are gradually released. The plasma concentration versus time profile of insulin glargine is therefore relatively constant in relation to conventional human insulins, with no pronounced peak over 24 hours. This allows once-daily administration as basal therapy. Early randomised trials with insulin glargine generally showed greater reductions in fasting blood or plasma glucose levels and a reduced frequency of nocturnal hypoglycaemia relative to neutral protamine Hagedorn (NPH) insulin in patients with type 1 diabetes mellitus. In addition to this basal therapy, patients continued to use the regular mealtime insulin regimen to which they were accustomed. More recent data with insulin glargine have included evidence of improved glycaemic control, with improvements in satisfaction with treatment over NPH insulin. Furthermore, the time of day at which insulin glargine is injected has no clinically relevant effect on glycaemic control in these patients. There are also data from small, nonblind studies to suggest comparable glycaemic control with insulin glargine and continuous subcutaneous insulin infusion. Results from comparative studies and meta-analyses in individuals with type 2 diabetes show lower incidences of nocturnal hypoglycaemia with insulin glargine than with NPH insulin, with two studies showing a significantly greater improvement in glycosylated haemoglobin levels with insulin glargine than with NPH. Insulin glargine is well tolerated, and is not associated with greater immunogenicity or increases in bodyweight than NPH insulin. Long-term data show maintenance of glycaemic control with insulin glargine for up to 39 months in adults and children with type 1 and adults with type 2 diabetes. In conclusion, insulin glargine is an effective and well tolerated basal insulin therapy when given as a single daily subcutaneous injection to patients with diabetes, with benefits in terms of glycaemic control and reduced frequency of hypoglycaemia over regimens based on conventional basal insulins. Accumulating data and official recommendations show the suitability of insulin glargine for first-line use in selected patients with type 2 diabetes who require insulin treatment, as well as in patients with type 1 disease, and confirm its use in children and adolescents.", 
        "genre": "research_article", 
        "id": "sg:pub.10.2165/00003495-200363160-00007", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1084788", 
            "issn": [
              "0012-6667", 
              "1179-1950"
            ], 
            "name": "Drugs", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "16", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "63"
          }
        ], 
        "name": "Insulin Glargine", 
        "pagination": "1743-1778", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "2f717c7088e09e96bcfee9b6501f84263bfa60c9dca243b3d7c66e7a6d9bce60"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "12904090"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "7600076"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.2165/00003495-200363160-00007"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1009958899"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.2165/00003495-200363160-00007", 
          "https://app.dimensions.ai/details/publication/pub.1009958899"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:39", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70046_00000000.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.2165/00003495-200363160-00007"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00003495-200363160-00007'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00003495-200363160-00007'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00003495-200363160-00007'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00003495-200363160-00007'


     

    This table displays all metadata directly associated to this object as RDF triples.

    311 TRIPLES      21 PREDICATES      96 URIs      35 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.2165/00003495-200363160-00007 schema:about N035ebb7bcd604cd18bbdc4cb47e229dd
    2 N0da5c4b631c841869f65181fb9f0bc1e
    3 N0f7358dfff8c48e19d5a39f986b0051b
    4 N284ce0872e774e85aef929db77448382
    5 N42c0218a1dcd43fc91aad86f15d997fa
    6 N711f42f797a946bba88cef13dceefcff
    7 N7a1599e6cc264f9283160bb4cf15ca1e
    8 Na21a240d443545aca0fe299f50ed6be8
    9 Na8edfc823a804dcb941a279628b83687
    10 Na9c92462f2b949baa9f0bcf3bfef3db4
    11 Nb5908f75c23048f9b7c46e9d8d32621b
    12 Nc4a9b06110164eb08c74370e0f6ed8b7
    13 Ne28fa455ee474c95b4c5b370e2b09638
    14 Nfb048a38f7ed46c5add3fccdad162106
    15 anzsrc-for:11
    16 anzsrc-for:1103
    17 schema:author Nbc2746630d2f453c8da585524641cc7a
    18 schema:citation sg:pub.10.2165/00003495-200161110-00007
    19 https://app.dimensions.ai/details/publication/pub.1074272220
    20 https://app.dimensions.ai/details/publication/pub.1075003279
    21 https://doi.org/10.1001/jama.289.17.2254
    22 https://doi.org/10.1002/pdi.383
    23 https://doi.org/10.1016/s0014-2999(96)00903-x
    24 https://doi.org/10.1016/s0140-6736(00)02546-0
    25 https://doi.org/10.1016/s0140-6736(98)07019-6
    26 https://doi.org/10.1016/s0140-6736(98)07037-8
    27 https://doi.org/10.1016/s0169-409x(98)00079-9
    28 https://doi.org/10.1046/j.1463-1326.2000.00109.x
    29 https://doi.org/10.1046/j.1464-5491.2001.00529.x
    30 https://doi.org/10.1046/j.1464-5491.2002.00723.x
    31 https://doi.org/10.1046/j.1464-5491.2003.00999.x
    32 https://doi.org/10.1053/bega.2002.0321
    33 https://doi.org/10.1055/s-2003-39080
    34 https://doi.org/10.1055/s-2007-978849
    35 https://doi.org/10.1056/nejm199309303291401
    36 https://doi.org/10.1056/nejm200002103420603
    37 https://doi.org/10.1080/003655100750019242
    38 https://doi.org/10.1080/10915810290096306
    39 https://doi.org/10.1080/10915810290096315
    40 https://doi.org/10.1097/00000446-200208000-00039
    41 https://doi.org/10.1111/j.1399-5448.2007.00252.x
    42 https://doi.org/10.1136/bmj.316.7139.1221
    43 https://doi.org/10.1136/bmj.321.7258.405
    44 https://doi.org/10.1185/030079902125001416
    45 https://doi.org/10.1210/edrv.22.5.0442
    46 https://doi.org/10.1210/jcem.86.12.8110
    47 https://doi.org/10.1515/jpem.2002.15.4.369
    48 https://doi.org/10.2337/diabetes.49.12.2142
    49 https://doi.org/10.2337/diabetes.49.6.999
    50 https://doi.org/10.2337/diacare.23.11.1666
    51 https://doi.org/10.2337/diacare.23.2.157
    52 https://doi.org/10.2337/diacare.23.5.639
    53 https://doi.org/10.2337/diacare.23.5.644
    54 https://doi.org/10.2337/diacare.23.6.813
    55 https://doi.org/10.2337/diacare.23.8.1130
    56 https://doi.org/10.2337/diacare.23.8.1137
    57 https://doi.org/10.2337/diacare.24.4.631
    58 https://doi.org/10.2337/diacare.25.6.1103-a
    59 https://doi.org/10.2337/diacare.25.9.1597
    60 https://doi.org/10.2337/diacare.25.9.1666
    61 https://doi.org/10.2337/diacare.26.2007.s25
    62 https://doi.org/10.2337/diacare.26.2007.s28
    63 https://doi.org/10.2337/diacare.26.2007.s33
    64 https://doi.org/10.2337/diacare.26.3.799
    65 https://doi.org/10.2337/diacare.26.4.1321
    66 https://doi.org/10.2337/diacare.26.4.1322
    67 https://doi.org/10.2337/diacare.26.5.1490
    68 https://doi.org/10.2337/diacare.26.6.1738
    69 https://doi.org/10.2337/diacare.26.7.2194
    70 https://doi.org/10.7326/0003-4819-138-12-200306170-00006
    71 schema:datePublished 2003-08
    72 schema:datePublishedReg 2003-08-01
    73 schema:description Insulin glargine is a human insulin analogue prepared by recombinant DNA technology. Modification of the human insulin molecule at position A21 and at the C-terminus of the B-chain results in the formation of a stable compound that is soluble at pH 4.0, but forms amorphous microprecipitates in subcutaneous tissue from which small amounts of insulin glargine are gradually released. The plasma concentration versus time profile of insulin glargine is therefore relatively constant in relation to conventional human insulins, with no pronounced peak over 24 hours. This allows once-daily administration as basal therapy. Early randomised trials with insulin glargine generally showed greater reductions in fasting blood or plasma glucose levels and a reduced frequency of nocturnal hypoglycaemia relative to neutral protamine Hagedorn (NPH) insulin in patients with type 1 diabetes mellitus. In addition to this basal therapy, patients continued to use the regular mealtime insulin regimen to which they were accustomed. More recent data with insulin glargine have included evidence of improved glycaemic control, with improvements in satisfaction with treatment over NPH insulin. Furthermore, the time of day at which insulin glargine is injected has no clinically relevant effect on glycaemic control in these patients. There are also data from small, nonblind studies to suggest comparable glycaemic control with insulin glargine and continuous subcutaneous insulin infusion. Results from comparative studies and meta-analyses in individuals with type 2 diabetes show lower incidences of nocturnal hypoglycaemia with insulin glargine than with NPH insulin, with two studies showing a significantly greater improvement in glycosylated haemoglobin levels with insulin glargine than with NPH. Insulin glargine is well tolerated, and is not associated with greater immunogenicity or increases in bodyweight than NPH insulin. Long-term data show maintenance of glycaemic control with insulin glargine for up to 39 months in adults and children with type 1 and adults with type 2 diabetes. In conclusion, insulin glargine is an effective and well tolerated basal insulin therapy when given as a single daily subcutaneous injection to patients with diabetes, with benefits in terms of glycaemic control and reduced frequency of hypoglycaemia over regimens based on conventional basal insulins. Accumulating data and official recommendations show the suitability of insulin glargine for first-line use in selected patients with type 2 diabetes who require insulin treatment, as well as in patients with type 1 disease, and confirm its use in children and adolescents.
    74 schema:genre research_article
    75 schema:inLanguage en
    76 schema:isAccessibleForFree false
    77 schema:isPartOf Na7f7d06f1d30481e87fea39f27a02c39
    78 Nca82ba4bb1d947eba6e1d9ad75d6ce78
    79 sg:journal.1084788
    80 schema:name Insulin Glargine
    81 schema:pagination 1743-1778
    82 schema:productId N8db1504aac574c91b4c1dcd92add4a7d
    83 Na217696aad0b4e369ef02108c49fd183
    84 Na4a75f84306a451c9073ca02c6847615
    85 Nc2aa461894da4335a454c0bc9c523652
    86 Nd3acd02f16734825b6778ebbdfa4d54b
    87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009958899
    88 https://doi.org/10.2165/00003495-200363160-00007
    89 schema:sdDatePublished 2019-04-11T12:39
    90 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    91 schema:sdPublisher N3ec396ee8ca944598615030ec229c8c2
    92 schema:url http://link.springer.com/10.2165/00003495-200363160-00007
    93 sgo:license sg:explorer/license/
    94 sgo:sdDataset articles
    95 rdf:type schema:ScholarlyArticle
    96 N035ebb7bcd604cd18bbdc4cb47e229dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Middle Aged
    98 rdf:type schema:DefinedTerm
    99 N09bf8c1b8ca94e57b0dc965c4151ce8a rdf:first sg:person.0726406660.79
    100 rdf:rest Naa419b892da943e89ab25df8b46aa456
    101 N0da5c4b631c841869f65181fb9f0bc1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Insulin, Long-Acting
    103 rdf:type schema:DefinedTerm
    104 N0f7358dfff8c48e19d5a39f986b0051b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Humans
    106 rdf:type schema:DefinedTerm
    107 N284ce0872e774e85aef929db77448382 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Insulin Glargine
    109 rdf:type schema:DefinedTerm
    110 N3ec396ee8ca944598615030ec229c8c2 schema:name Springer Nature - SN SciGraph project
    111 rdf:type schema:Organization
    112 N42c0218a1dcd43fc91aad86f15d997fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Time Factors
    114 rdf:type schema:DefinedTerm
    115 N711f42f797a946bba88cef13dceefcff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Drug Administration Schedule
    117 rdf:type schema:DefinedTerm
    118 N7a1599e6cc264f9283160bb4cf15ca1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Injections, Subcutaneous
    120 rdf:type schema:DefinedTerm
    121 N8db1504aac574c91b4c1dcd92add4a7d schema:name pubmed_id
    122 schema:value 12904090
    123 rdf:type schema:PropertyValue
    124 Na217696aad0b4e369ef02108c49fd183 schema:name nlm_unique_id
    125 schema:value 7600076
    126 rdf:type schema:PropertyValue
    127 Na21a240d443545aca0fe299f50ed6be8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Insulin
    129 rdf:type schema:DefinedTerm
    130 Na4a75f84306a451c9073ca02c6847615 schema:name dimensions_id
    131 schema:value pub.1009958899
    132 rdf:type schema:PropertyValue
    133 Na7f7d06f1d30481e87fea39f27a02c39 schema:issueNumber 16
    134 rdf:type schema:PublicationIssue
    135 Na8edfc823a804dcb941a279628b83687 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Aged
    137 rdf:type schema:DefinedTerm
    138 Na9c92462f2b949baa9f0bcf3bfef3db4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Treatment Outcome
    140 rdf:type schema:DefinedTerm
    141 Naa419b892da943e89ab25df8b46aa456 rdf:first sg:person.01175750452.33
    142 rdf:rest Nf1af23a4b5a0448cb2a6fe34c68fd367
    143 Nb5908f75c23048f9b7c46e9d8d32621b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Adult
    145 rdf:type schema:DefinedTerm
    146 Nbc2746630d2f453c8da585524641cc7a rdf:first sg:person.0700313355.98
    147 rdf:rest N09bf8c1b8ca94e57b0dc965c4151ce8a
    148 Nc2aa461894da4335a454c0bc9c523652 schema:name doi
    149 schema:value 10.2165/00003495-200363160-00007
    150 rdf:type schema:PropertyValue
    151 Nc4a9b06110164eb08c74370e0f6ed8b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Diabetes Mellitus
    153 rdf:type schema:DefinedTerm
    154 Nca82ba4bb1d947eba6e1d9ad75d6ce78 schema:volumeNumber 63
    155 rdf:type schema:PublicationVolume
    156 Nd3acd02f16734825b6778ebbdfa4d54b schema:name readcube_id
    157 schema:value 2f717c7088e09e96bcfee9b6501f84263bfa60c9dca243b3d7c66e7a6d9bce60
    158 rdf:type schema:PropertyValue
    159 Ndc25ba1dbc454f2aa9cd68370e6da645 rdf:first sg:person.01244653776.31
    160 rdf:rest rdf:nil
    161 Ne28fa455ee474c95b4c5b370e2b09638 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Adolescent
    163 rdf:type schema:DefinedTerm
    164 Nf1af23a4b5a0448cb2a6fe34c68fd367 rdf:first sg:person.01100307753.15
    165 rdf:rest Ndc25ba1dbc454f2aa9cd68370e6da645
    166 Nfb048a38f7ed46c5add3fccdad162106 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name United Kingdom
    168 rdf:type schema:DefinedTerm
    169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    170 schema:name Medical and Health Sciences
    171 rdf:type schema:DefinedTerm
    172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Clinical Sciences
    174 rdf:type schema:DefinedTerm
    175 sg:journal.1084788 schema:issn 0012-6667
    176 1179-1950
    177 schema:name Drugs
    178 rdf:type schema:Periodical
    179 sg:person.01100307753.15 schema:affiliation https://www.grid.ac/institutes/grid.420067.7
    180 schema:familyName McKeage
    181 schema:givenName Kate
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100307753.15
    183 rdf:type schema:Person
    184 sg:person.01175750452.33 schema:affiliation https://www.grid.ac/institutes/grid.420067.7
    185 schema:familyName Keating
    186 schema:givenName Gillian M.
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175750452.33
    188 rdf:type schema:Person
    189 sg:person.01244653776.31 schema:affiliation https://www.grid.ac/institutes/grid.420067.7
    190 schema:familyName Scott
    191 schema:givenName Lesley J.
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244653776.31
    193 rdf:type schema:Person
    194 sg:person.0700313355.98 schema:affiliation https://www.grid.ac/institutes/grid.420067.7
    195 schema:familyName Dunn
    196 schema:givenName Christopher J.
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700313355.98
    198 rdf:type schema:Person
    199 sg:person.0726406660.79 schema:affiliation https://www.grid.ac/institutes/grid.420067.7
    200 schema:familyName Plosker
    201 schema:givenName Greg L.
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726406660.79
    203 rdf:type schema:Person
    204 sg:pub.10.2165/00003495-200161110-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013714316
    205 https://doi.org/10.2165/00003495-200161110-00007
    206 rdf:type schema:CreativeWork
    207 https://app.dimensions.ai/details/publication/pub.1074272220 schema:CreativeWork
    208 https://app.dimensions.ai/details/publication/pub.1075003279 schema:CreativeWork
    209 https://doi.org/10.1001/jama.289.17.2254 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019986510
    210 rdf:type schema:CreativeWork
    211 https://doi.org/10.1002/pdi.383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013862196
    212 rdf:type schema:CreativeWork
    213 https://doi.org/10.1016/s0014-2999(96)00903-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013847532
    214 rdf:type schema:CreativeWork
    215 https://doi.org/10.1016/s0140-6736(00)02546-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032757605
    216 rdf:type schema:CreativeWork
    217 https://doi.org/10.1016/s0140-6736(98)07019-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018881858
    218 rdf:type schema:CreativeWork
    219 https://doi.org/10.1016/s0140-6736(98)07037-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015697368
    220 rdf:type schema:CreativeWork
    221 https://doi.org/10.1016/s0169-409x(98)00079-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011220920
    222 rdf:type schema:CreativeWork
    223 https://doi.org/10.1046/j.1463-1326.2000.00109.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038882295
    224 rdf:type schema:CreativeWork
    225 https://doi.org/10.1046/j.1464-5491.2001.00529.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023118109
    226 rdf:type schema:CreativeWork
    227 https://doi.org/10.1046/j.1464-5491.2002.00723.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1022928206
    228 rdf:type schema:CreativeWork
    229 https://doi.org/10.1046/j.1464-5491.2003.00999.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001455083
    230 rdf:type schema:CreativeWork
    231 https://doi.org/10.1053/bega.2002.0321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030345651
    232 rdf:type schema:CreativeWork
    233 https://doi.org/10.1055/s-2003-39080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057421544
    234 rdf:type schema:CreativeWork
    235 https://doi.org/10.1055/s-2007-978849 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057508289
    236 rdf:type schema:CreativeWork
    237 https://doi.org/10.1056/nejm199309303291401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004144761
    238 rdf:type schema:CreativeWork
    239 https://doi.org/10.1056/nejm200002103420603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012627827
    240 rdf:type schema:CreativeWork
    241 https://doi.org/10.1080/003655100750019242 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034245644
    242 rdf:type schema:CreativeWork
    243 https://doi.org/10.1080/10915810290096306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058377172
    244 rdf:type schema:CreativeWork
    245 https://doi.org/10.1080/10915810290096315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058377173
    246 rdf:type schema:CreativeWork
    247 https://doi.org/10.1097/00000446-200208000-00039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007787360
    248 rdf:type schema:CreativeWork
    249 https://doi.org/10.1111/j.1399-5448.2007.00252.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1019524362
    250 rdf:type schema:CreativeWork
    251 https://doi.org/10.1136/bmj.316.7139.1221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028197140
    252 rdf:type schema:CreativeWork
    253 https://doi.org/10.1136/bmj.321.7258.405 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000154862
    254 rdf:type schema:CreativeWork
    255 https://doi.org/10.1185/030079902125001416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022039494
    256 rdf:type schema:CreativeWork
    257 https://doi.org/10.1210/edrv.22.5.0442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064238544
    258 rdf:type schema:CreativeWork
    259 https://doi.org/10.1210/jcem.86.12.8110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064324076
    260 rdf:type schema:CreativeWork
    261 https://doi.org/10.1515/jpem.2002.15.4.369 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029076833
    262 rdf:type schema:CreativeWork
    263 https://doi.org/10.2337/diabetes.49.12.2142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012893424
    264 rdf:type schema:CreativeWork
    265 https://doi.org/10.2337/diabetes.49.6.999 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052181318
    266 rdf:type schema:CreativeWork
    267 https://doi.org/10.2337/diacare.23.11.1666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000892396
    268 rdf:type schema:CreativeWork
    269 https://doi.org/10.2337/diacare.23.2.157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000907601
    270 rdf:type schema:CreativeWork
    271 https://doi.org/10.2337/diacare.23.5.639 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005928670
    272 rdf:type schema:CreativeWork
    273 https://doi.org/10.2337/diacare.23.5.644 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040323572
    274 rdf:type schema:CreativeWork
    275 https://doi.org/10.2337/diacare.23.6.813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052130317
    276 rdf:type schema:CreativeWork
    277 https://doi.org/10.2337/diacare.23.8.1130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050330235
    278 rdf:type schema:CreativeWork
    279 https://doi.org/10.2337/diacare.23.8.1137 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046985393
    280 rdf:type schema:CreativeWork
    281 https://doi.org/10.2337/diacare.24.4.631 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022125555
    282 rdf:type schema:CreativeWork
    283 https://doi.org/10.2337/diacare.25.6.1103-a schema:sameAs https://app.dimensions.ai/details/publication/pub.1039095989
    284 rdf:type schema:CreativeWork
    285 https://doi.org/10.2337/diacare.25.9.1597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013972289
    286 rdf:type schema:CreativeWork
    287 https://doi.org/10.2337/diacare.25.9.1666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000728386
    288 rdf:type schema:CreativeWork
    289 https://doi.org/10.2337/diacare.26.2007.s25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045453861
    290 rdf:type schema:CreativeWork
    291 https://doi.org/10.2337/diacare.26.2007.s28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051982466
    292 rdf:type schema:CreativeWork
    293 https://doi.org/10.2337/diacare.26.2007.s33 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047132498
    294 rdf:type schema:CreativeWork
    295 https://doi.org/10.2337/diacare.26.3.799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047194220
    296 rdf:type schema:CreativeWork
    297 https://doi.org/10.2337/diacare.26.4.1321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035157988
    298 rdf:type schema:CreativeWork
    299 https://doi.org/10.2337/diacare.26.4.1322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001924345
    300 rdf:type schema:CreativeWork
    301 https://doi.org/10.2337/diacare.26.5.1490 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038524974
    302 rdf:type schema:CreativeWork
    303 https://doi.org/10.2337/diacare.26.6.1738 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018387725
    304 rdf:type schema:CreativeWork
    305 https://doi.org/10.2337/diacare.26.7.2194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027671378
    306 rdf:type schema:CreativeWork
    307 https://doi.org/10.7326/0003-4819-138-12-200306170-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073706003
    308 rdf:type schema:CreativeWork
    309 https://www.grid.ac/institutes/grid.420067.7 schema:alternateName Springer (New Zealand)
    310 schema:name Adis International Limited, 41 Centorian Drive, Private Bag 65901, 1311, Mairangi Bay, Auckland, New Zealand
    311 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...